BamSEC and AlphaSense Join Forces
Learn More

Zyla Life Sciences

Formerly OTC: ZCOR

Latest Filings – Non-Ownership Filter

15-12B
Securities registration termination
06/01/20
8-K
Assertio Completed Merger With Zyla Life Sciences Trading Under ASRT on Nasdaq Global Select Market Combined Company Pro Forma 2019 Net Product Sales of Approximately $128 Million1 Upwards of $40 Million in Expected Cost Synergies
05/20/20
8-K
Termination of Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Material Modification to Rights of Security Holders, Change of Control, Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits
05/20/20
25
Removal from listing
05/20/20
S-8 POS
Amendment to registration of securities for employees
05/20/20
S-8 POS
######### ## ############ ## ########## ### #########
05/20/20
425
######## ########### ##########
05/15/20
8-K
## #### ######
05/15/20
425
######## ########### ##########
05/15/20
8-K
####### ##### ####### #### ######### #######
05/15/20
10-Q
ended 12/34/56 ##
05/14/20
DEFA14A
########## #### ##### ######## ####
05/01/20
10-K/A
ended 12/34/56 ## #### ####### #######
04/28/20
DEF 14A
########## #####
04/20/20
425
######## ########### ##########
04/13/20
8-K
###### ## ########## ######## ## ############# ##### ######
04/13/20
425
######## ########### ##########
03/27/20
8-K
####### ###### ####### ### #### #### #### ######### #######
03/27/20
S-8
############ ## ########## ### #########
03/27/20
10-K
ended 12/34/56 ## ####
03/26/20